Biotech | January 25, 2023
CrisprBits develops CRISPR-based SARS-CoV2 test OmiCrisp
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
The unit will have installed manufacturing capacity of over 15 million vials annually that includes lyophilized vials, all in the anti-cancer segment
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Subscribe To Our Newsletter & Stay Updated
